NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 11516.65 -15.75 -0.14%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ABAXIS, Inc. (NASDAQ: ABAX)

 
ABAX Technical Analysis
1.5
As on 31st Oct 2017 ABAX Share Price closed @ 48.40 and we RECOMMEND Sell for LONG-TERM with Stoploss of 48.97 & Buy for SHORT-TERM with Stoploss of 46.02 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ABAX Share Price

Open 47.87 Change Price %
High 48.74 1 Day 0.54 1.13
Low 47.48 1 Week 0.00 0.00
Close 48.40 1 Month 2.50 5.45
Volume 110567 1 Year -2.83 -5.52
52 Week High 55.95 | 52 Week Low 43.66
 
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
INTC 45.49 2.52%
 
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
 
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
 
 
ABAX
Daily Charts
ABAX
Intraday Charts
Whats New @
Bazaartrend
ABAX
Free Analysis
 
ABAX Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE49.57
RESISTANCE49.09
SUPPORT47.71
SUPPORT47.23
SUPPORT0.00
SUPPORT0.00
 
ABAX Target for Month March
4th UP TARGET61.97
3rd UP TARGET57.62
2nd UP TARGET54.93
1st UP TARGET52.24
1st DOWN TARGET44.56
2nd DOWN TARGET41.87
3rd DOWN TARGET39.18
4th DOWN TARGET34.83
 
ABAX Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
ABAX Target for Year 2019
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
ABAX Other Details
Segment EQ
Market Capital 814564224.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.abaxis.com
 
ABAX Address
ABAX
3240 Whipple Road
Union City, CA 94587
United States
Phone: 510-675-6500
Fax: 510-441-6150
 
ABAX Latest News
 
Your Comments and Response on ABAXIS, Inc.
 
ABAX Business Profile
Abaxis, Inc. (Abaxis), incorporated on January 12, 1989, develops, manufactures, markets and sells blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements. The Company’s segments include the medical market and the veterinary market. The Company has developed a blood analysis system incorporating all of these criteria into a 5.1 kilogram (11.2 pounds) portable analyzer and a series of menu-specific, multi-test single-use reagent discs. Abaxis markets its blood chemistry analyzers in the medical market and in the veterinary market. The Company markets the blood analysis system in the medical market under the name Piccolo Xpress. It markets the blood analysis system in the veterinary market under the name VetScan VS2. The Company product include blood analysis system, consisting of a compact portable analyzer and a series of single-use plastic discs, called reagent discs, containing all the chemicals required to perform a panel of up to 14 tests on human patients and 13 tests on veterinary patients. The products manufactured and sold in the medical market segment consist of Piccolo chemistry analyzers and medical reagent discs. Abaxis Headquarters is at 3240 Whipple Road, Union City, CA 94587, United States of America.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service